Using computerized alerts to improve cholesterol treatment in patients with Peripheral Artery Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of an alert-based computerized decision support tool, known as EPIC Best Practice Advisory (BPA), in increasing the prescription of LDL-C-lowering therapies among patients with Peripheral Artery Disease (PAD) who are currently not receiving such treatments. The study involves 400 patients and aims to address the underutilization of guideline-directed therapies by providing timely alerts to both patients and healthcare providers. The trial is conducted at a single center, Brigham and Women's Hospital, and focuses on improving adherence to clinical guidelines for managing cholesterol levels in PAD patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients ≥ 18 years old
* Seen in Cardiovascular Medicine Clinic, Primary Care, Podiatry, Vascular Surgery, and Diabetology
* Medical history entry, visit diagnosis, or problem list entry of PAD
* Not prescribed LDL-C-lowering therapy

Exclusion Criteria:

* Patients taking a statin, ezetimibe, bempedoic acid, a PCSK9 inhibitor, inclisiran or a combination will be excluded

Where it's running

• Brigham and Women's Hospital
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Gregory Piazza — Bwh
• Study coordinator: Gregory Piazza
• Email: gpiazza@bwh.harvard.edu
• Phone: 6177326984

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of a medication on blood vessel function and walking ability in people with peripheral artery disease

  This study is testing if a medication called diroximel fumarate can help improve blood vessel function and walking ability in people aged 50-75 with peripheral artery disease.

  Recruiting Early Phase 1 University of Nebraska · Omaha, Nebraska · NCT06319339

• Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome

  This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.

  Recruiting University of Applied Sciences in Nowy Targ · Nowy Targ, Lesser Poland Voivodeship · NCT07917364

• Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events

  In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.

  Recruiting Phase 4 Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07796217

• Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD

  This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.

  Recruiting Laval University · Lévis, Quebec · NCT07655206

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• Group visits to help manage high cholesterol

  This project will try group medical visits for adults with dyslipidemia to see if they improve care, lifestyle habits, and access to primary care.

  Recruiting Université de Sherbrooke · Dieppe, New Brunswick · NCT07543718

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.